Drawing for HEMOLUMI

USPTO serial 79276710

HEMOLUMI

Reviewed by CopyMark Law Group

Reg. 6366592Status 707Renewal
Filing date
Status date
Registration date
Jun 1, 2021
Examiner
LAM, HAI-LY HUYNH
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with HEMOLUMI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alex D. Patel

Alex D. Patel Patel IP, P.C.20700 Ventura Blvd., Suite #235Woodland Hills, CA 91364United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic reagents for medical purposes; reagents for medical purposes; chemical preparations for medical purposes, namely, for blood coagulation and anticoagulation, fibrinolysis and anti-fibrinolysis functional analysis, and for quantitative or qualitative detection of various analytes in human serum, plasma or other body fluids; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes; [ dietetic substances adapted for medical use, namely, dietetic sugar for medical use, dietetic infusions for medical use; air purifying preparations; ] diagnostic reagents for veterinary purposesACTIVE—
009[ Computer programs, recorded, for controlling the operation of blood coagulation analyzing apparatus and instruments; computer operating programs, recorded; computer peripheral devices; recorded computer software for data analysis and processing; data processing equipment, namely, couplers; interfaces for computers; downloadable computer programs for monitoring data from medical imaging apparatus; downloadable electronic publications, namely, books, hand-outs, and workbooks in the field of business; downloadable computer software applications for use in blood coagulation analyzing apparatus and instruments control, for controlling mobile phones, portable media players, and handheld computers, for remotely controlling other PC software, and for database management and electronic storage of data; computer software applications, downloadable, namely, software for use in database management and electronic storage of data ]SECTION 71 - CANCELLED—
010Medical apparatus and instruments, namely, automatic blood analyzers featuring a blood coagulation module and immunoassay module; diagnostic apparatus for medical purposes, namely, blood coagulation analyzing apparatus and instruments; blood testing apparatus; apparatus for blood analysis; testing apparatus for medical purposes, namely, blood testing apparatus [ ; special containers especially adapted for the disposal of medical devices, syringes and other contaminated medical waste; containers especially made for medical waste; medical ultrasound equipment; suture materials; dental apparatus and instruments, namely, dental drills, dental picks, dental excavators ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 21, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 21, 202671.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Sep 20, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 30, 2026ES71TEAS SECTION 71 RECEIVED—
Jul 22, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 22, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 22, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 22, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 22, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 22, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 1, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 29, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 17, 2021XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 17, 2021XXCRGENERIC MADRID TRANSACTION CREATED—
Sep 1, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 1, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 16, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 16, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 14, 2021GPNXNOTIFICATION PROCESSED BY IB—
Feb 24, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 24, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 24, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 9, 2021ALIEASSIGNED TO LIE—
Feb 9, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 2, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Feb 2, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 2, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 2, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 7, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 6, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 6, 2021ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 19, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 19, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 19, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 29, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 29, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 29, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2020RFNTREFUSAL PROCESSED BY IB—
Mar 10, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 9, 2020RFRRREFUSAL PROCESSED BY MPU—
Feb 19, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 18, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2020DOCKASSIGNED TO EXAMINER—
Jan 28, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 24, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 23, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance